CCM
MDCXW

Connective Capital Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Connective Capital Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.36K Hold
6,000
– – ﹤0.01% 65
2025
Q4 		$4.8K Hold
6,000
– – ﹤0.01% 55
2025
Q3 		$4.32K Hold
6,000
– – ﹤0.01% 71
2025
Q2 		$5.3K Hold
6,000
– – 0.01% 48
2025
Q1 		$4.2K Hold
6,000
– – ﹤0.01% 43
2024
Q4 		$2.11K Buy
+6,000
New +$3.84K ﹤0.01% 67

Other funds holding MDCXW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Connective Capital Management's MDCXW Position: Q1 2026 in Review

Connective Capital Management held its Medicus Pharma Warrant (MDCXW) position steady in Q1 2026 at 6,000 shares worth $3.36K. The position accounts for ﹤0.01% of the portfolio, ranked #65.

Connective Capital Management first reported a position in MDCXW in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.3K in Q2 2025. 6 funds tracked by Wall St. Rank hold MDCXW as of Q1 2026.

  • Connective Capital Management held 6,000 shares of Medicus Pharma Warrant worth $3.36K as of Q1 2026.
  • Connective Capital Management left its Medicus Pharma Warrant share count unchanged in Q1 2026.
  • Medicus Pharma Warrant made up ﹤0.01% of Connective Capital Management's portfolio in Q1 2026, its #65 holding.
  • Connective Capital Management first reported a position in Medicus Pharma Warrant in Q4 2024 and has held it in 6 quarters since.
  • Connective Capital Management's Medicus Pharma Warrant position peaked at $5.3K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q1 2026.

Based on Connective Capital Management's 13F filing for Q1 2026, filed 13 May 2026.